Oncology-focused diagnostic assays including tumor markers and genetic testing solutions. Developed with clinical evidence, validated processes, and regulatory pathways established for market approval.
Manufactured by
France
Helio Diagnostics is a European, independent CDMO dedicated to In Vitro Diagnostics (IVD), designed to support long-term partnerships with diagnostic and life sciences companies worldwide. With more than 25 years of industrial IVD expertise and an ISO 13485-certified manufacturing site in France, Helio Diagnostics provides a reliable European platform for companies seeking to scale, industrialize, or access the EU market. Helio Diagnostics supports partners end-to-end, from feasibility and assay development to IVDR support, scalable manufacturing, EU batch release, global logistics, and full lifecycle management. Non-competing and partner-first by design, Helio Diagnostics offers flexible engagement models, fast feasibility timelines, and transparent execution to help partners de-risk development, accelerate time to market, and build sustainable diagnostic businesses in Europe and beyond.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Diatech Pharmacogenetics srl
Italy · 1 relevant product
Roche Pharma
Switzerland · 2 relevant products
PHC Corporation
Japan · 2 relevant products
73 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →21 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 96 closest product alternatives
Diatech Pharmacogenetics srl · Italy
Molecular diagnostic testing for oncology patients to support faster diagnosis and identification of appropriate therapeutic options. Reduces turnaround time for molecular testing to enable faster clinical decision-making.
Roche Pharma · Switzerland
Diagnostic solutions for cancer screening, diagnosis, and treatment monitoring.
PHC Corporation · Japan
Laboratory testing services specializing in cancer detection and identification through tissue analysis and biomarker assessment. These services support early detection and treatment planning for cancer patients.
93 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products